A phase 1 study of PF-07242813, an anti-CD1a antibody, in healthy participants and in patients with atopic dermatitis. // JID Innovations. – URL: https://www.sciencedirect.com/science/article/pii/S2667026726000779?dgcid=rss_sd_all
A phase 1 study of PF-07242813, an anti-CD1a antibody, in healthy participants and in patients with atopic dermatitis. JID Innovations. https://www.sciencedirect.com/science/article/pii/S2667026726000779?dgcid=rss_sd_all
“A phase 1 study of PF-07242813, an anti-CD1a antibody, in healthy participants and in patients with atopic dermatitis.” JID Innovations.
@article{article51298,
title = {A phase 1 study of PF-07242813, an anti-CD1a antibody, in healthy participants and in patients with atopic dermatitis},
journal = {JID Innovations},
url = {https://www.sciencedirect.com/science/article/pii/S2667026726000779?dgcid=rss_sd_all}
}